Core 1 ? Expression and Molecular Biology (EMB) Core PROJECT SUMMARY/ABSTRACT The overall goal of SBDR-4 is to characterize the DNA repair multi-protein machines and assemblies that maintain genomic integrity and to identify the mechanisms that underlie detection and signaling of the damage, in order to recruit repair machines to the damage site for repair. The proposed SBDR research will provide mechanistic, predictive biology for cancer interventions through a framework built upon structural and functional understanding of DNA repair machines. The major challenges faced by SBDR-4 include: (1) efficient reconstitution and assembly of full-length and modified proteins and complexes that control integrity of the genome, (2) determining the solution structures of flexible multi-protein complexes that are spatially and temporally regulated in cells, and (3) linking structures to biochemistry and cellular phenotypes. The Expression and Molecular Biology (EMB) Core will overcome the technical aspects of these bottlenecks by implementing robust DNA assembly technologies, incorporating efficient protein purification strategies, and developing advanced tools for cellular studies. The EMB Core services will empower SBDR-4 by providing high-quality key starting materials for cell biological, biochemical, biophysical, and structural investigations of DNA repair machines. The EMB Core will serve as a research, production, and development resource for all five Projects by providing dedicated Core staff and centralized expertise. The EMB Core will develop robust pipelines for (1) construction of single-gene and multi-gene expression vectors, (2) creation of isogenic human cell lines with designed changes, (3) streamlined scaled-up expression technologies, (4) purification of well- behaved, functional DNA repair proteins and complexes, and (5) validation of protein interactions and partnerships. The innovative technologies provided by EMB Core to enable SBDR-4 research include: (1) high- efficiency cloning of multi-gene vectors using advanced DNA assembly technologies, e.g. the BioBrick-based MacroBac system, Gibson assembly and Golden Gate assembly; (2) incorporation of cleavable GFP tags and application of GFP-binder single-chain nanobody columns for efficient purification of multimeric protein complexes for in vitro analysis; and (3) developing novel cellular tools using a novel, highly effective CRISPR knock-in (KI) method to create isogenic human cell lines with desired changes, as well as using the HIV-TAT methodology to produce interfering peptides for cellular studies. The EMB Core thus offers a robust blend of established and new technologies and efficiently provides reagents to jump-start Project Aims and cross- Project interactions for characterizing transient interactions and dynamic conformations that control the assembly and function of multi-protein complexes in response to DNA damage to maintain genomic stability.

Public Health Relevance

Core 1 ? Expression and Molecular Biology (EMB) Core PORJECT NARRATIVE The proposed research and production services and new technology platforms developed by the Expression and Molecular Biology (EMB) Core will provide centralized and critical resources for the SBDR Program and create significant synergy with all five Projects. We will accelerate the pace of proposed SBDR research on the DNA Repair machines that serve to maintain genomic integrity to achieve the SBDR goal of mechanistic, predictive biology for improved cancer interventions that will be highly relevant to public health.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA092584-18
Application #
9548576
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2018-09-01
Budget End
2019-08-31
Support Year
18
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Lawrence Berkeley National Laboratory
Department
Type
DUNS #
078576738
City
Berkeley
State
CA
Country
United States
Zip Code
94720
Sung, Patrick (2018) Introduction to the Thematic Minireview Series: DNA double-strand break repair and pathway choice. J Biol Chem 293:10500-10501
Shen, Jianfeng; Ju, Zhenlin; Zhao, Wei et al. (2018) ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade. Nat Med 24:556-562
Sengupta, Shiladitya; Yang, Chunying; Hegde, Muralidhar L et al. (2018) Acetylation of oxidized base repair-initiating NEIL1 DNA glycosylase required for chromatin-bound repair complex formation in the human genome increases cellular resistance to oxidative stress. DNA Repair (Amst) 66-67:1-10
Mu, Hong; Geacintov, Nicholas E; Broyde, Suse et al. (2018) Molecular basis for damage recognition and verification by XPC-RAD23B and TFIIH in nucleotide excision repair. DNA Repair (Amst) :
Chavez, Diana A; Greer, Briana H; Eichman, Brandt F (2018) The HIRAN domain of helicase-like transcription factor positions the DNA translocase motor to drive efficient DNA fork regression. J Biol Chem 293:8484-8494
Wang, Jing L; Duboc, Camille; Wu, Qian et al. (2018) Dissection of DNA double-strand-break repair using novel single-molecule forceps. Nat Struct Mol Biol 25:482-487
Crickard, J Brooks; Kaniecki, Kyle; Kwon, Youngho et al. (2018) Meiosis-specific recombinase Dmc1 is a potent inhibitor of the Srs2 antirecombinase. Proc Natl Acad Sci U S A 115:E10041-E10048
Syed, Aleem; Tainer, John A (2018) The MRE11-RAD50-NBS1 Complex Conducts the Orchestration of Damage Signaling and Outcomes to Stress in DNA Replication and Repair. Annu Rev Biochem 87:263-294
Howes, Timothy R L; Sallmyr, Annahita; Brooks, Rhys et al. (2018) Erratum to ""Structure-activity relationships among DNA ligase inhibitors; characterization of a selective uncompetitive DNA ligase I inhibitor"" [DNA Repair 60C (2017) 29-39]. DNA Repair (Amst) 61:99
Bhattacharyya, Sudipta; Soniat, Michael M; Walker, David et al. (2018) Phage Mu Gam protein promotes NHEJ in concert with Escherichia coli ligase. Proc Natl Acad Sci U S A 115:E11614-E11622

Showing the most recent 10 out of 484 publications